Classic Hodgkin Lymphoma

Classic Hodgkin Lymphoma is a type of cancer that originates in white blood cells called lymphocytes, which are part of the body’s immune system. This condition primarily affects the lymphatic system, a network of vessels and glands that help fight infection.

Classic Hodgkin Lymphoma

Key Takeaways

  • Classic Hodgkin Lymphoma (CHL) is a cancer of the lymphatic system, characterized by the presence of Reed-Sternberg cells.
  • Common symptoms include swollen, painless lymph nodes, fever, night sweats, and unexplained weight loss.
  • Diagnosis involves physical examination, imaging scans, blood tests, and a definitive lymph node biopsy.
  • Treatment options typically include chemotherapy, radiation therapy, and sometimes immunotherapy or stem cell transplantation, tailored to the disease stage.

What is Classic Hodgkin Lymphoma?

Classic Hodgkin Lymphoma (CHL) is a specific subtype of Hodgkin lymphoma, a cancer that develops in the lymphatic system. It is distinguished by the presence of large, abnormal cells known as Reed-Sternberg cells, which are derived from B lymphocytes. These cancerous cells proliferate in the lymph nodes, spleen, liver, bone marrow, and other organs, impairing the immune system’s ability to function effectively.

CHL is one of the more curable forms of cancer, especially when detected early. According to the American Cancer Society, Hodgkin lymphoma accounts for about 0.5% of all cancers diagnosed in the United States annually, with Classic Hodgkin Lymphoma being the most common type, making up about 95% of all Hodgkin lymphoma cases.

Symptoms and Diagnosis of Classic Hodgkin Lymphoma

Recognizing the signs of Classic Hodgkin Lymphoma is crucial for early detection and effective treatment. The most common of the classic hodgkin lymphoma symptoms is the painless enlargement of lymph nodes, often in the neck, armpit, or groin. However, other systemic symptoms, often referred to as ‘B symptoms,’ can also occur.

  • Persistent fever (without infection)
  • Drenching night sweats
  • Unexplained weight loss (more than 10% of body weight in six months)
  • Generalized itching (pruritus)
  • Fatigue
  • Loss of appetite

The process of diagnosing classic hodgkin lymphoma typically begins with a thorough physical examination, where a doctor checks for swollen lymph nodes and an enlarged spleen or liver. This is followed by a series of diagnostic tests. Imaging studies, such as CT scans, PET scans, and MRI, help determine the extent of the disease within the body. Blood tests can provide information about overall health and organ function, but the definitive diagnosis relies on a lymph node biopsy. During a biopsy, a small piece of an affected lymph node is removed and examined under a microscope for the characteristic Reed-Sternberg cells.

Classic Hodgkin Lymphoma Treatment Options

Once Classic Hodgkin Lymphoma is diagnosed and staged, a personalized treatment plan is developed. The primary classic hodgkin lymphoma treatment options aim to eliminate the cancer cells and prevent recurrence. The choice of treatment depends on several factors, including the stage of the cancer, the patient’s age and overall health, and the presence of any specific symptoms.

Chemotherapy is a cornerstone of CHL treatment, often involving a combination of drugs administered in cycles. Radiation therapy, which uses high-energy rays to kill cancer cells, may be used alone or in conjunction with chemotherapy, particularly for localized disease. For patients with advanced or recurrent disease, other options may include immunotherapy, which helps the body’s immune system fight cancer, or high-dose chemotherapy followed by a stem cell transplant, which replaces diseased bone marrow with healthy stem cells. Ongoing research continues to refine these treatments, leading to improved outcomes for patients with Classic Hodgkin Lymphoma.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.